Mast cell signaling machinery

The mast cell signaling machinery is a complex network of receptors, kinases, and adapter proteins that coordinate the activation, degranulation, and mediator release of mast cells (Galli & Tsai, 2012). The primary pathway is initiated by the cross-linking of the high-affinity IgE receptor (FcεRI) by IgE-antigen complexes, which recruits and activates Src-family kinases such as Lyn and Fyn, followed by Spleen tyrosine kinase (Syk) (Gilfillan & Rivera, 2009). These signaling events trigger downstream cascades involving phospholipase C gamma (PLCγ) and calcium mobilization, leading to the rapid release of preformed mediators like histamine and tryptase, as well as the synthesis of leukotrienes and cytokines (Siraganian et al., 2010). In addition to FcεRI, other receptors such as MRGPRX2 and the c-Kit receptor contribute to the activation, survival, and proliferation of mast cells, further expanding the complexity of this signaling network (McNeil et al., 2015). This machinery plays a central role in the pathogenesis of Type I hypersensitivity reactions, including asthma, allergic rhinitis, and anaphylaxis, as well as in mast cell proliferative disorders like systemic mastocytosis (Valent et al., 2017). Therapeutic strategies targeting this machinery include the use of mast cell stabilizers, anti-IgE antibodies, and small-molecule inhibitors of key signaling nodes such as BTK, Syk}

Other names

Mast cell activation pathwayFcεRI signaling cascadeMast cell degranulation pathwayMast cell signaling network

The machinery is targeted through multiple mechanisms: sequestration of IgE to prevent receptor binding, stabilization of the cell membrane to inhibit degranulation, and pharmacological inhibition of key signaling enzymes such as Spleen tyrosine kinase (Syk), Bruton's tyrosine kinase (BTK), and the c-Kit receptor (Olivera et al., 2018; Gilfillan & Rivera, 2009).